Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Circulation
|
August 9, 2017
When Lightning Strikes: Fulminant Myocarditis in the Realm of Inflammatory Cardiomyopathies
Leslie T Cooper
Circulation
|
September 6, 2013
Role of left ventricular biopsy in the management of heart disease
Leslie T Cooper
Circulation
|
February 26, 2024
Myocarditis: Entering the Mainstream
Leslie T Cooper
Circulation
|
April 17, 2020
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Nicholas S Hendren, Mark H Drazner, Biykem Bozkurt, et al.
Circulation
|
May 17, 2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases
Leslie T Cooper, George A Mensah, Larry M Baddour, et al.
Circulation
|
July 7, 2021
Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association
Yuk M Law, Ashwin K Lal, Sharon Chen, et al.
Circulation
|
October 26, 2007
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Leslie T Cooper, Kenneth L Baughman, Arthur M Feldman, et al.
Circulation
|
April 30, 2014
Cardiac magnetic resonance imaging in giant cell myocarditis: intriguing associations with clinical and pathological features
Yasumori Sujino, Fumiko Kimura, Jun Tanno, et al.
Circulation
|
January 7, 2020
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association
Robb D Kociol, Leslie T Cooper, James C Fang, et al.
Circulation
|
December 2, 2015
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology
Barry J Maron, James E Udelson, Robert O Bonow, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Circulation
|
August 9, 2017
When Lightning Strikes: Fulminant Myocarditis in the Realm of Inflammatory Cardiomyopathies
Leslie T Cooper
Circulation
|
September 6, 2013
Role of left ventricular biopsy in the management of heart disease
Leslie T Cooper
Circulation
|
February 26, 2024
Myocarditis: Entering the Mainstream
Leslie T Cooper
Circulation
|
April 17, 2020
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Nicholas S Hendren, Mark H Drazner, Biykem Bozkurt, et al.
Circulation
|
May 17, 2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases
Leslie T Cooper, George A Mensah, Larry M Baddour, et al.
Circulation
|
July 7, 2021
Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association
Yuk M Law, Ashwin K Lal, Sharon Chen, et al.
Circulation
|
October 26, 2007
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Leslie T Cooper, Kenneth L Baughman, Arthur M Feldman, et al.
Circulation
|
April 30, 2014
Cardiac magnetic resonance imaging in giant cell myocarditis: intriguing associations with clinical and pathological features
Yasumori Sujino, Fumiko Kimura, Jun Tanno, et al.
Circulation
|
January 7, 2020
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association
Robb D Kociol, Leslie T Cooper, James C Fang, et al.
Circulation
|
December 2, 2015
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology
Barry J Maron, James E Udelson, Robert O Bonow, et al.
Page
of 2